Background {#Sec1}
==========

The global reemergence of syphilis as a common and clinically significant sexually transmitted infection (STI) is forcing healthcare providers to search for the new elements driving this epidemic. It is estimated that worldwide, there are nearly twelve million new infections with syphilis annually \[[@CR1]\]. Syphilis rates in Canada more than doubled between 2003 (2.9/100,000) and 2012 (5.8/100,000), with the rates increasing among females by 40.9% and in males by 128.3% \[[@CR2]\]. In the Canadian province of Alberta, the rates of new cases of syphilis increased dramatically between 2014 and 2015 nearly doubling in number, with over 25% of cases occurring in patients co-infected with HIV \[[@CR3]\].

Syphilis, similar to other STI's, acts synergistically with HIV, both increasing susceptibility to infection and leading to worse health outcomes \[[@CR4]--[@CR6]\]. Asymptomatic or undiagnosed syphilis negatively impacts HIV prognoses by reducing CD4 counts and increasing viral loads making early syphilis detection important when delivering HIV care \[[@CR5]--[@CR8]\]. Recent studies have suggested that HIV-infected patients, while receiving consistent HIV care, may continue to engage in sexual activities placing themselves at high risk for acquiring other STI's \[[@CR9], [@CR10]\]. The suppression of HIV viral replication (HIV viral load \< 1000 copies/mL) using antiretroviral therapy (ART) resulting in minimal risk for sexual transmission of HIV has received legal recognition in Canada \[[@CR11]--[@CR15]\].

This increase in episodes of syphilis being seen in southern Alberta prompted the Calgary STI Program (CSTI) and the Southern Alberta Clinic (SAC), to coordinate their initiatives to improve syphilis screening in those engaged in HIV care. In this retrospective cohort study, we aimed to characterize incident syphilis episodes in HIV-infected individuals, assessing patient demographics and markers of HIV control. Such knowledge may be essential for developing improved and targeted preventative strategies especially for patients engaged in ongoing HIV care.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

SAC and CSTI are the sole referral agencies for both syphilis and HIV within the region, facilitating inclusivity of this retrospective cohort study. SAC provides HIV care to all HIV-infected individuals living within southern Alberta, Canada and CSTI provides all health care services for STI's from testing to treatment.

In a quality assurance project (approved by University of Calgary Bioethics committee) at both SAC and CSTI programs, routine serologic screening for syphilis regardless of risk accompanied regular four-month HIV viral load measurements between January 1, 2006 and December 31, 2016. The records of all episodes of incident syphilis infection occurring in HIV-infected patients were reviewed. Every indeterminate or positive syphilis serology for a SAC patient was discussed with or referred to CSTI at the time of testing.

All individuals followed at SAC with at least one regular visit between January 1, 2006 and December 31, 2016 were included in this study (*N* = 2448). Patients were followed until December 31, 2016 or until they either moved, died or were lost-to-follow-up. All patients, who while in HIV care, converted from being seronegative for syphilis to a confirmed positive status or were re-infected with syphilis were reviewed through the SAC database and a CSTI chart review. A control population was identified through the SAC database to be used for comparison of demographic data and included all HIV-infected patients followed at SAC with at least one regular visit between January 1, 2006 and December 31, 2016 whose treponemal or non treponemal syphilis test remained negative.

Syphilis diagnosis {#Sec4}
------------------

The syphilis screening algorithm and confirmatory testing was achieved using indirect serologic methods. Initially screening for syphilis was done with the non-treponemal rapid plasma reagin (RPR), however in 2008 the screening test was changed to an enzyme immunoassay (EIA), a treponemal test. The RPR continued to be used as a confirmatory test as well as for monitoring response to therapy. In Calgary, the secondary confirmatory test was either the fluorescent treponemal antibody absorption test (FTA-ABS) or the line immunoassay (INNO-LIA). Repeat syphilis episodes were identified by a four-fold increase in RPR after a prior documented successful treatment course for syphilis and were evaluated and staged by an STI specialist (RR).

Data collection {#Sec5}
---------------

Clinical and sociodemographic data was obtained from a review of both SAC and CSTI databases and charts for all patients included in the study. These data included: age at HIV diagnosis; gender (i.e. male, female, transgendered), self-reported ethnicity (i.e. Caucasian, Indigenous, African/Caribbean/Black (ACB), Other); most likely HIV exposure risk (i.e. MSM-self-reported men who have sex with men identification, HET- self-reported heterosexual identification, PWID- self-reported persons who inject drugs, Other), and year of HIV diagnosis. Other self-reported data fields included cigarette smoking (current or past), alcohol abuse (\> 14 drinks/week or self-described binge drinking), recreational drug use (i.e. intravenous drug use), intimate partner violence exposure (current, past and/or childhood abuse), and ever unstable housing (i.e. homelessness, transitional housing, shelters, supported housing).

For patients with an incident syphilis infection, detailed standardized information was collected by one physician (RL), through a comprehensive review of both SAC and CSTI charts and databases. Multiple sources including nursing interviews, social work reports, self-administered questionnaires, laboratory reports and routine STI and HIV care notes from charts and databases were used. These data included self-described sexual practices, ART use and HIV viral loads collected both prior to and after each positive syphilis test. Prior history of comorbid infections including *Neisseria gonorrhoeae*, *Chlamydia trachomatis* and Hepatitis C virus (HCV*)* were self-reported and documented in CSTI charts at the time of syphilis diagnosis.

During routine HIV appointments, all patients were asked if they were sexually active and if the activities would be considered "unsafe" (condomless sex). For those engaging in unsafe sexual practices, counselling on both HIV and STI transmission risks was provided. The number of self-reported sexual partners in the period six months prior to testing positive for syphilis was documented. All data was anonymized prior to analysis.

Statistical analysis {#Sec6}
--------------------

Demographic and risk factors of patients in control group were compared with those with syphilis infection, those with repeat episodes of syphilis, those not on ART, and those not virally suppressed (viral load \> 40 copies/ml) using chi-squared testing. Age and sex adjusted incident rate (IR) of syphilis infection were calculated from 2006 to 2016 using the 2006 demographic as reference. Incidence rates adjusted for HIV risk exposure in addition to age and sex were also analyzed. Incidence rates were calculated using patients "active in care," meaning they had attended at least one SAC visit each year to contribute to a patient-year of follow up. All statistical analysis was performed using Stata, (version 15.0 College Station, TX). All charts were created with Microsoft Excel.

Results {#Sec7}
=======

Between 1/1/2006 and 12/31/2016, the mean number of patients "active in care" at SAC was 1517 per year (range: 1086 in 2006 to 1889 in 2016). During this time, there were 20,203 syphilis tests done on a total of 2448 patients who attended at least one regular SAC visit. On average, there were 180 days between each syphilis test per patient. The average number of syphilis screening tests that were done per patient each year over the 11-year period was 2.1. In 2006 the average number of tests per year was 1.3, whereas in 2016 this was 2.8. For high risk patients (MSM) screening rates were more frequent with the average testing over 11 years being 2.4 tests per year. The average number of viral load measurements per patient per year was 3.03 (range 2.58--3.37).

Of the 2448 HIV-infected patients followed at SAC and CSTI during the study period, encompassing 15,175 person-years, we identified 360 potential episodes of syphilis in 305 different patients that met the broad study criteria for incident syphilis. Of the 360 potential episodes, 38 were excluded after being classified as false positive syphilis tests. Inadequate availability of comprehensive data led to exclusion of 32 episodes along with 41 additional episodes, who although tested in Alberta, had since moved out of province. These episodes were not included in incident rate calculations as validity of the tests ensuring incident infection as well as characteristics of the diagnosis were not available. We therefore analyzed 249 episodes in 194 individuals. Over half (50.8%) of incident syphilis cases were asymptomatic and were only identified by routine screening. In 71/249 (28.5%) of the infections, syphilis occurred in individuals who had previously been successfully treated for syphilis on one or more past occasions and were identified by a four-fold increase in RPR titer.

The average IR between 2006 and 2016 was 12.88 per 1000 person-years of follow up (95% confidence interval (CI): 9.64--16.11). When adjusted for HIV exposure category in addition to age and sex, the average IR between 2006 and 2016 was 13.22 per 1000 person-years of follow up (95% CI: 8.20--21.34). Incident rates decreased from 15.50 in 2006 (95% CI: 9.04--26.35) to 5.87 in 2008 (95% CI: 2.68--12.77). The rise in syphilis rates in 2009 (Fig. [1](#Fig1){ref-type="fig"}) are likely reflective in part to a change in the testing algorithm for syphilis in Calgary from an initial RPR to enzyme immunoassay (EIA). In 2008, the screening test was changed to an EIA resulting in increased identification of latent syphilis due to improved sensitivity of the test and likely resulting in the increasing rate of syphilis demonstrated in 2009 and 2010. Annual incidence rates tripled from 2011 8.08/1000 patient-years (95% CI: 4.14--14.75), to 27.04 per 1000 person-years (95% CI: 19.45--36.76) in 2016 (Fig. [1](#Fig1){ref-type="fig"}). The number of repeat syphilis infections climbed from three repeat episodes in 2011 (25% of all syphilis infections during that year), up to 20 in 2016 (44%) (Fig. [2](#Fig2){ref-type="fig"}).Fig. 1Age and Sex adjusted Incidence Rates among Individuals with HIV in Care at Southern Alberta Clinic 2006--2016. This figure demonstrates the rise in incident rate per 1000 patient years of syphilis infection in the HIV-infected individuals at SAC between 2006 and 2016Fig. 2Repeat Incident Episodes of Syphilis in the HIV Positive Individuals Per Year. This figure is demonstrating the number of syphilis infection each year divided by number of repeat infection. As seen there has been an increase in number of syphilis episodes from 2006 to 2016, however the number of repeat cases has also increased

Demographics {#Sec8}
------------

The incident syphilis infections were seen mainly in males (94%) compared to the control group (74%, *P* = \< 0.001), with MSM being the leading HIV exposure risk group (75% vs 40.6%, *P* = \< 0.001) and in Caucasians (72% vs. 56%), *P* = \< 0.001). Compared to HIV-infected but with no evidence of past or current syphilis infection, those with syphilis were more likely to have a history of alcohol abuse (28% vs. 18%, *P* = \< 0.001) and a history of recreational drug use (44% vs. 31%, *P* = \< 0.001) (Table [1](#Tab1){ref-type="table"}). Co-infections with other STI's (*C. trachomatis, N. gonorrhoeae,* HCV*)* at time of syphilis infection were very common with 42% of the population studied having had at least one other STI prior to incident syphilis infection other than HIV. STI co-infections included; 32% of cases having a prior history of *N. gonorrhoeae*, 24% having had documented *C. trachomatis* and 1.5% were also co-infected with HCV.Table 1Characteristics of HIV+ patients regularly followed at the Southern Alberta Clinic between 1/1/2006 and 12/31/2016 comparing patients who were negative for syphilis (Syphilis Neg) to patients who ever tested positive for syphilis (Syphilis Pos)TotalSyphilis NegSyphilis Pos*P*-valueN (%)24482254 (92.1)194 (7.9)Age at HIV Diagnosis (years)Mean (range)35 (1--79)35 (1--79)35 (16--69)0.893\< 30888 (36.2)813 (36.1)75 (38.7)0.80130--39868 (35.5)802 (35.6)66 (34.0)40--49475 (19.4)438 (19.4)37 (19.1)≥ 50217 (8.9)201 (8.9)16 (8.3)GenderMale1858 (75.9)1675 (74.3)183 (94.3)\<.001Female583 (23.8)572 (25.4)11 (5.6)Transgendered7 (0.3)7 (0.3)0 (0.0)Self-reported Ethnicity^a^Caucasian1399 (57.1)1259 (56.0)140 (72.2)\<.001Indigenous222 (9.1)216 (9.6)6 (3.1)ACB560 (22.9)536 (23.8)24 (12.4)Other267 (10.9)243 (10.8)24 (12.4)Most Likely HIV Exposure Category^b^MSM1060 (43.3)915 (40.6)145 (74.4)\<.001HET526 (21.5)512 (22.7)14 (7.2)PWID761 (31.1)731 (32.4)30 (15.6)Other101 (4.1)96 (4.3)5 (2.6)Co-factors^c^History of Smoking1252 (51.1)1142 (50.7)110 (56.7)0.124History of Alcohol Abuse460 (18.8)404 (17.9)56 (28.9)\<.001History of RecreationalDrug Use794 (32.4)707 (31.4)87 (44.8)\<.001History of UnstableHousing516/2109483/193233/1770.073(24.5)(25.0)(18.6)History of IntimatePartner Violence655 (26.7)614 (27.2)41 (21.1)0.079^a^Native Canadian includes Aboriginal, Metis and Inuit; ACB includes African, Caribbean, Black; Other includes IndoAsian, Hispanic, East Asian, and other^b^MSM = self-reported men who have sex with men identification; HET = self-reported heterosexual identification; PWID = self-reported intravenous drug use identification; Other HIV Risk factor behavior includes: blood transfusions, hemophiliac, neonatal, postnatal infection, unknown or not reported^c^History of Cigarette Smoking-Current or Past; History of Alcohol Abuse- \> 14 drinks/week or binge drinking; History of Recreational Drug Use --Current or Past; History of Unstable Housing-homelessness, shelters, supporatative housing; History of Intimate Partner Violence-Current or Past

Engagement with HIV care and disclosure of sexual activity {#Sec9}
----------------------------------------------------------

The mean age at syphilis diagnosis was 47 years (range of 21--72); the mean length of time between the HIV positive test and a positive syphilis test was 7.7 years (range 0.1--25.6) with 31% having been HIV positive for greater than 10 years (Table [2](#Tab2){ref-type="table"}). The mean duration of HIV care at SAC was 4.9 years (0.1--23.3) with 16% having been followed for greater than 10 years. At the visit prior to acquiring syphilis, only 59% stated that they were currently sexually active; however, following diagnosis with syphilis, 71% reported sexual activity. There were 144/193 (75%) patients diagnosed with syphilis that reported having 1 to 5 sexual partners in the preceding 6 months of their syphilis diagnosis; mean number of partners was 4.7 and median being 2. Counselling on safer sexual practices was provided for 44% of the individuals at the clinic visit immediately prior to testing positive for syphilis and 50% received safer sex counselling at the appointment immediately following syphilis infection.Table 2Characteristics of HIV+ patients active in care at SAC or CSTI at time of their syphilis diagnosis between 1/1/2006 and 12/31/2016. (Note − 158 patients had a single syphilis episode; 36 patients had more than 1 episode. *N* = 249 syphilis episodes total)Length of time in years between HIV diagnosis and Syphilis diagnosis (*n* = 249)Mean (range)7.7 (0.1--25.6)\< 1 year (N/%)26 (10)1--5 years82 (33)6--1064 (26)\> 10 years77 (31)Age in years at time of each Syphilis diagnosis (*n* = 249)Mean (range)47 (21--72)\< 30 (N/%)43 (17)30--3974 (30)40--4981 (33)50--5937 (15)\> 5914 (6)Length of time in years followed in care at SAC (*n* = 249)Mean (range)4.9 (0.1--23.3)\< 1 (N/%)77 (31)1--5101 (41)6--1031 (12)11--1524 (10)\> 1516 (6)Number of self-reported sexual partners within the preceding 6 months of a syphilis diagnosis (*n* = 193)Mean (range)4.7 (0--50)0 (N/%)14 (7)1--5144 (75)6--1015 (8)11--156 (3)16--208 (4)\> 206 (3)

HIV control at syphilis diagnosis {#Sec10}
---------------------------------

At the time of their incident syphilis infection, nearly 1 in 5 (19%) of patients were not on ART in contrast to 11% of other HIV-infected patients in care in the same time period. Those not on ART with incident syphilis were more likely to be PWID (23%), compared to those on ART (16%, *P* = \< 0.004). Self-reported alcohol abuse was also more common in those not on ART (33% vs. 29%, *P* = 0.024) (Additional file [1](#MOESM1){ref-type="media"}: Table S1).

At the time of syphilis infection, nearly one-third (30.5%; 75/249) of patients had detectable HIV viremia (ranging from 49 to 2,309,021 copies/mL) (Table [3](#Tab3){ref-type="table"}). This included 19% of patients that had viral loads greater than 1000 copies/mL and 4% had viral loads of greater than 100,000 copies/mL. In patients with viral loads \> 40 copies/mL at syphilis diagnosis, 52% were not on ART. These patients with detectable viremia were predominately male (96%, *P* = 0.002), Caucasian (77%, *P* = 0.04) and MSM (73%, *P* = \< 0.001) and a greater proportion were PWID (20%, *P* = \< 0.001) (Additional file [1](#MOESM1){ref-type="media"}: Table S1).Table 3Subgroup analysis of individuals with HIV and incident syphilis infection based on virologic supression^a^, patients not on antiretroviral therapy (ART) and those with repeat syphilis episodesEpisodes of syphilis in individuals with HIV that were not virologically suppressed, VL ≤ 40 copies/mL (*n* = 75/249)Number of EpisodesPercentageOn ART3648Not on ART3952Episodes of syphilis in individuals with HIV that are not on ART (*n* = 48/249)Number of EpisodesPercentageViral Load (range) copies/mL\< 40--2,309,021≤ 402441--39948400--10,0001838≥ 10,0002450Episodes of syphilis in individuals with HIV and repeat syphilis infections (*n* = 71/249)Number of EpisodesPercentageVirologic suppression (range)\< 40--330,000Virologically suppressed4563Not Virologically suppressed2637On ART5882Not on ART1318^a^HIV Virologic suppression defined as \< 40 copies/mL

Subgroup analysis: Repeat episodes of syphilis {#Sec11}
----------------------------------------------

Over one-quarter (28%) of syphilis infections occurred in individuals previously successfully treated for a past episode and were identified by a four-fold increase in RPR. Over two-thirds (47/71) were second episodes of syphilis, with 21% (15/71) experiencing syphilis for the third time, 9% (6/71) for the fourth time and 4% (3 individuals) for the fifth time. Those experiencing repeat episodes of syphilis were more likely male (97%, *P* = 0.007), Caucasian (75%, *P* = 0.001) and MSM (92%, *P* = \< 0.001) compared to those in the control population of HIV-infected, syphilis negative individuals. A trend towards current or past recreational drug use (47%, *P* = 0.064) was noted but not reaching significance in those with repeat infections (Additional file [1](#MOESM1){ref-type="media"}: Table S1). A history of other STI's were very common in this subgroup with a prior history of *N. gonorrhoeae* (47%) and *C. trachomatis* (39%).

Discussion {#Sec12}
==========

In many countries, the rate of new syphilis infections in HIV-infected patients is increasing \[[@CR16], [@CR17]\]. We found that the annual incidence rate of new syphilis infections in patients regularly engaged in HIV care at SAC has nearly tripled since 2011. Overall, 8% of all SAC patients have experienced one or more syphilis episodes during the past 10 years; 1 in 7 (13.5%) MSM individuals at SAC have been diagnosed with syphilis. Over half (50.8%) of the new infections were asymptomatic and only identified by routine screening during HIV care, underscoring the importance and value in routine screening in this risk population. Over 1 in 4 (28%) of previously diagnosed patients with syphilis had one or more subsequent syphilis episodes.

These results are disconcerting as patients in this study had been successfully engaged in care for an average of 5 years with over 15% followed for 10 years or more. Patients routinely are screened for syphilis approximately every 4 months, and are counselled on safe sex practices on an ongoing basis. By routinely screening patients we have likely identified increased numbers of asymptomatic syphilis episodes that were diagnosed, however this does not explain the increasing number of incident infections and our failure in curtailing this epidemic.

STI prevention may be achieved through counselling and education \[[@CR18]--[@CR20]\]. Flemming et al. stated that three key areas need to be addressed in programmatic developments addressing STI infections in HIV-infected populations including improving access to clinical services, promoting early and effective STI related healthcare behaviors and lastly, establishing successful screening systems \[[@CR21]\]. To be cost effective, novel programing must be focused towards those at greatest risk of incident syphilis infection. High risk groups identified for acquiring syphilis among HIV-infected populations include MSM, current or prior alcohol abuse disorder, history of recreational drug use and prior syphilis diagnosis.

As in other reports, men accounted for most of our new syphilis infections with the majority having MSM as their risk activity for their HIV \[[@CR3], [@CR17]\]. The successful use of ART in almost eliminating HIV transmission risk in adherent patients has been proposed as a contributing factor to increased unprotected sex and subsequent STI's: this link is as yet unproven \[[@CR10]--[@CR15]\]. The CDC reports the highest absolute rates of syphilis in those aged 30--39, our data however, identifies that the highest rate of syphilis in our patients occurs between 40 and 49 years of age \[[@CR4]\]. This may be attributable to successful ART allowing HIV-infected patients to live longer, remain in good health and be involved in ongoing sexual relationships \[[@CR12]\]. Less attention towards safer sex practices and lower uptake of STI testing among the older cohort may also be contributing factors \[[@CR21]\].

Coinfection with STIs including *N. gonorrhoeae*, *C. trachomatis*, and HCV has shown to have implications for HIV treatment and transmission \[[@CR22]--[@CR25]\]. With the knowledge that over 40% of these patients had prior or current STIs including *N. gonorrhoeae* and *C. trachomatis*, regular screening is recommended as it has been shown to increase early detection and prevent subsequent transmission \[[@CR22], [@CR17], [@CR24], [@CR25]\].

Over one quarter of the syphilis infections were repeat infections. The frequency of repeat infections is increasing over time, while in 2009, only 14% of the incident infections were repeat episodes by 2016, 44% were repeat infections. This is mirrored by a study published by Phipps et al. that evaluated repeat syphilis infections between 2001 and 2002 among MSM in San Francisco and found that of 642 patients with diagnosis of syphilis, 63% were co-infected with HIV and 6.7% were repeat infections within one year of prior syphilis diagnosis \[[@CR6]\].

Of Public Health concern those with repeat infections were more likely to have detectable HIV viremia when compared to those with initial syphilis episodes. This subpopulation requires intensive investigation as repeat syphilis infection indicates continued high risk behaviors and in the setting of also having HIV viral load \> 1000 copies/mL increases the risk of HIV transmission \[[@CR4], [@CR11]--[@CR15]\]. As such, they may benefit most from comprehensive preventative programs, including counselling and education, increased frequency of screening, outreach interventions and possibly STI pre-exposure prophylaxis \[[@CR4], [@CR25]--[@CR28]\].

We found that patients at the time of their syphilis episode were nearly twice as likely to not be on ART as those with HIV but negative for syphilis. Furthermore, in 19% of cases, the patients diagnosed with syphilis had HIV viremia \> 1000 copies/mL potentially increasing their risk of HIV transmission to uninfected partners \[[@CR11], [@CR15]\]. HIV PrEP has had success in the prevention of HIV transmission, and its use in the context of the current syphilis epidemic is being evaluated. Bolan et al. undertook a pilot study in 2015, providing doxycycline prophylaxis to reduce incident syphilis among HIV-infected MSM. Their results showed that STI PrEP with doxycycline was associated with a decreased incidence of *N. gonorrhoeae*, *C. trachomatis* and syphilis in this population \[[@CR27]\].

Post exposure prophylaxis with doxycycline has also been shown to reduce the overall incidence in bacterial STI's in HIV-infected MSM, however the long-term benefit is still unknown and therefore antibiotic prophylaxis for STI's is currently not recommended in guidelines \[[@CR28]\]. This may be an avenue for primary prevention of syphilis in HIV-positive individuals in regular care and characterized to be high risk for syphilis infection.

Our study has limitations. We only address patients who are accessing care. The incident rates reported may be an under estimate as they do not include individuals infected but lost to follow up and do not include those who were diagnosed with syphilis in Alberta, however subsequently moved out of province, resulting in inadequate follow up data. Although the study population, while comprehensive and representing a regional Canadian perspective, is from a single regional area and may not be representative populations elsewhere that have different rates of unprotected sexual activity and both prevalent HIV and syphilis infections. In addition, access to care varies between centers and populations and our rates and identification methods may not precisely match others. In our population, however care for both HIV and STI care is centralized and well-coordinated, allowing for detailed analyses.

Conclusions {#Sec13}
===========

Increasing incident syphilis infections among the HIV-infected population in care is an emerging public health concern. Highlighted is the importance of a regular syphilis screening program as half of the syphilis infections identified were asymptomatic, diagnosis prompted not only earlier treatment but also identified patients with high risk sexual behaviors. Regular safer sex counselling in our program has not been effective in limiting syphilis acquisition in those successfully engaged in HIV care. A number of risk factors among HIV-infected populations were identified, including; MSM, prior alcohol abuse, prior recreational drug use and prior syphilis episode. Intensified and novel interventions will be required for those at high risk if the negative consequences of syphilis are to be avoided and its spread curtailed.

Additional file
===============

 {#Sec14}

Additional file 1:**Table S1.** Characteristics of HIV+ patients regularly followed at the Southern Alberta Clinic between 1/1/2006 and 12/31/2016 comparing patients in four groups: syphilis positive (reference group), repeat syphilis positive, syphilis positive not on ART, syphilis positive not HIV Virologically suppressed (VL \> 40 copies/mL). ^1^Indigenous includes Aboriginal, Metis and Inuit; ACB includes African, Caribbean, Black; Other includes IndoAsian, Hispanic, East Asian, and other. ^2^MSM = self-reported men who have sex with men identification; HET = self-reported heterosexual identification; PWID = self-reported intravenous drug use identification; Other HIV Risk factor behavior includes: blood transfusions, hemophiliac, neonatal, postnatal infection, unknown or not reported. ^3^History of Cigarette Smoking-Current or Past; History of Alcohol Abuse- \> 14 drinks/week or binge drinking; History of Recreational Drug Use --Current or Past; History of Intimate Partner Violence-Current or Past. (DOCX 24 kb)
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